Is NPHP4 p.Gly545Asp (c.1634G>A) pathogenic?

NPHP4 p.Gly545Asp (c.1634G>A) is classified Conflicting classifications of pathogenicity in NPHP4 (ClinVar, Conflicting submitters, 4 submitters; last evaluated 2025-07-01). AlphaMissense: likely benign (0.154); Ultra-rare (popmax 0.073%, sas); Associated with nephronophthisis.

What condition is associated with NPHP4 p.Gly545Asp (c.1634G>A)?

NPHP4 p.Gly545Asp (c.1634G>A) is associated with nephronophthisis, nephronophthisis 4, Senior-Loken syndrome 4 (ClinVar).

How common is NPHP4 p.Gly545Asp (c.1634G>A) in the general population?

NPHP4 p.Gly545Asp (c.1634G>A) is ultra-rare (popmax 0.073%, sas) (gnomAD).

How is Nephronophthisis inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

What do computational predictors say about NPHP4 p.Gly545Asp (c.1634G>A)?

AlphaMissense predicts likely benign (score 0.154) — an in-silico prediction, not a clinical call.

NPHP4 p.Gly545Asp

c.1634G>A · rs200800785 · VCV847939

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 4 submitters

AlphaMissense

likely benign

0.154 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.073%, sas)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

nephronophthisis

Computational evidence

Protein change
AlphaMissense	0.154	likely benign
REVEL	0.261	benign-leaning
SaProt	LLR -4.66	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	<0.2	no splice effect predicted · four deltas, not one · how we know
Constraint at this position
Conservation	phyloP 3.8	GERP 2.1, phastCons 0.53
Regional constraint	o/e 1.02	unconstrained · MANE · 123 kb · p 0.49 · regional, not allelic
Overall
CADD	13.76	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.073% South Asian · 66/90,362 alleles

Filtering AF 0.0588% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0537%

Overall 0.00813% 131/1,610,606 alleles · ultra-rare exomes 121/1,458,444 · genomes 10/152,162 · joint denominator

Ancestry group	Frequency	1 in
South Asiangrpmax	0.073%	1,369
Remaining individualsnot grpmax-eligible	0.00802%	12,472
European (non-Finnish)	0.00509%	19,640

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: NPHP4
Protein: p.Gly545Asp
Coding: c.1634G>A
MANE Select: NM_015102
dbSNP: rs200800785
Type: single nucleotide variant
Location: chr1:5905761 (GRCh38)
Gene constraint: LOEUF 1.183 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 72.44

Full NPHP4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nephronophthisis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: nephronophthisis 4 Senior-Loken syndrome 4

For Nephronophthisis (Orphanet):

Inheritance: Autosomal recessive
Onset: Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Prevalence: 1-9 / 100 000 (Finland)

Similar variants

NPHP4 p.Gly545Ala Uncertain significance ★ ⚠ same residue
NPHP4 p.Gly545Ser Uncertain significance ★ ⚠ same residue
NPHP4 p.Gly545= Likely benign ★ same residue
NPHP4 c.2304+1G>A Pathogenic ★★ same condition
NPHP4 c.2611+1G>A Pathogenic/Likely pathogenic ★★ same condition
NPHP4 c.2611+1G>C Pathogenic ★★ same condition
NPHP4 c.3644+1G>A Pathogenic/Likely pathogenic ★★ same condition
NPHP4 c.3644+1G>T Pathogenic/Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp4-p-gly545asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown